Search | IOVS | ARVO Journals

Showing 1 – 20 of 97

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Cornea & External Disease October 2024

Key Clinical and Histopathological Features of a Pterygium-Like Induced Lesion in a Rabbit Model

PDF

Carlos A. Rodríguez-Barrientos; Gloria Regina Ayala-Villegas; Jorge E. Valdez-García; Judith Zavala
TAGS: histopathology tests, oryctolagus cuniculus, pterygium
Trans. Vis. Sci. Tech.. 2024; 13(10):1. https://doi.org/10.1167/tvst.13.10.1

ARVO Annual Meeting Abstract June 2024

Key clinical features of the progression of a Pterygium-Like Induced Lesion in a rabbit model

Gloria Regina Ayala Villegas; Carlos A Rodríguez-Barrientos; Alfredo Ruiz-Montenegro; Judith Zavala; Jorge E Valdez

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3617.

ARVO Annual Meeting Abstract June 2024

Effect of low-dose Sedum sp. lyophilate in sodium hyaluronate solution on the resazurin viability assay of human pterygium fibroblasts

Alfredo Ruiz-Montenegro; Emilio Piñeyro; Gloria Regina Ayala Villegas; Judith Zavala; Jorge E Valdez

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3634.

ARVO Annual Meeting Abstract June 2024

Safety profile of Siempreviva formulation in an in vivo model

David Eugenio Rodriguez Fuentes; Katiana Flores Nucamendi; Gloria Regina Ayala Villegas; Carlos A Rodríguez-Barrientos; Judith Zavala; Jorge E Valdez

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4598.

ARVO Annual Meeting Abstract June 2024

Efficacy and Safety of Off-Label Subconjunctival Ranibizumab for Pterygium Recurrence

Jorge E Valdez; Eugenia Margarita Ramos Dávila; Jan Moisés Guillén-Ortiz; José Carlos Guerrero-Acosta

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3641.

ARVO Annual Meeting Abstract June 2024

Therapeutic effect of a Siempreviva formulation in a pterygium in vivo model

Katiana Flores Nucamendi; David Eugenio Rodriguez Fuentes; Gloria Regina Ayala Villegas; Carlos A Rodríguez-Barrientos; Judith Zavala; Jorge E Valdez

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3607.

ARVO Annual Meeting Abstract June 2024

Establishing Optimal Parameters for Tissue Engineered Corneal Endothelium

Itzel Becerril; Judith Zavala; Hannia M Macias; Carlos A Rodríguez-Barrientos; Jorge E Valdez

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4485.

ARVO Annual Meeting Abstract June 2024

Clinical Features and Treatment Outcomes in Patients Diagnosed with Late LASIK Ectasia

Luis Guillermo Villagomez Valdez; Raul E. Ruiz Lozano; Eugenia Margarita Ramos Dávila; Lucas Antonio Garza-Garza; Daniel Bastán-Fabián; Jorge Eugenio Valdez-García

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1073.

ARVO Annual Meeting Abstract June 2024

Visual acuity and refraction in patients with LASIK enhancement

Daniel Bastán-Fabián; Raul E. Ruiz Lozano; Guillermo Villagómez-Valdez; Gustavo Adolfo Ortiz-Morales; Jorge Eugenio Valdez-García

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1055.

ARVO Annual Meeting Abstract June 2024

From Retina to Cornea: Quantifying the Impact of Diabetic Retinopathy on Dry Eye Disease and Corneal Sensitivity

José Carlos Guerrero Acosta; Raul E. Ruiz Lozano; Pedro Mario González Madrigal; Alejandro Rodriguez-García; Guillermo García de la Rosa; Jorge Eugenio Valdez-García; Daniel Bastán-Fabián; Eugenia Margarita Ramos Dávila; Julian Navarro Saucedo

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2949.

ARVO Annual Meeting Abstract June 2024

Clinical Profile of Ophthalmology Patients Using Biologic Therapy and Predictive Factors for Switching

Eugenia Margarita Ramos Dávila; Carlos Manuel Rusque-Lavalle; Patricio Garza-Villarreal; Raul E. Ruiz-Lozano; Carlos Alvarez-Guzman; Alejandro Rodriguez-García; Jorge Eugenio Valdez-García

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2600.

ARVO Annual Meeting Abstract June 2024

Enhanced Wound Healing in a Conjunctival Epithelial Cell Scratch Assay via Platelet and Leukocyte Rich Plasma Enriched in Platelet-Derived Growth Factor

Emilio Piñeyro; Alberto Castillo; Carlos A Rodríguez-Barrientos; Judith Zavala; Jorge Eugenio Valdez-García

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3638.

ARVO Annual Meeting Abstract June 2024

Degradation Rate and Water Absorption Characterization of Collagen Membranes for Corneal Tissue Engineering

Hannia M Macias; Itzel Becerril; Judith Zavala; Carlos A Rodríguez-Barrientos; Jorge Eugenio Valdez-García

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4482.

ARVO Annual Meeting Abstract June 2024

Meibomian gland dysfunction treated with a novel device: A case series

Raul Trejo Treviño; Daniel Bastán-Fabián; José Carlos Guerrero-Acosta; Jan Moisés Guillén-Ortiz; Jorge Eugenio Valdez-García

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6581.

Public Health October 2023

Underrepresentation of Low- and Middle-Income Nations in Ophthalmology Journals: A Critical Analysis on Diversity, Equity, and Global Representation

PDF

Eugenia M. Ramos-Dávila; Irving A. Domínguez-Varela; Raul E. Ruiz-Lozano; Luis Guillermo Villagómez-Valdez; Diego I. Lopez-Zúñiga; Mildred Vanessa Lopez-Cabrera; Jorge E. Valdez-García
TAGS: editorial board, equity, income, ophthalmology, underrepresented groups
Trans. Vis. Sci. Tech.. 2023; 12(10):9. https://doi.org/10.1167/tvst.12.10.9

ARVO Annual Meeting Abstract June 2023

Corneal Biomechanical Metrics by Corvis ST in a Healthy Mexican Population

Daniela Fabregas-Sanchez-Woodworth; Arturo J Ramirez-Miranda; Simran Mangwani Mordani; José Y. Arteaga Rivera; David Jimenez-Collado; Alejandro Navas; Enrique O Graue-Hernandez; Jorge E Valdez; Alondra Mendizabal-Velazquez

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1699.

ARVO Annual Meeting Abstract June 2023

Quality-adjusted life year analysis of engineered corneal endothelium transplant for a Hispanic Population

Jorge E Valdez; Marge Vaikjarv; Cirian Oneill; Sead Zejnel; Gabriela Tavcioska; Judith Zavala

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2355.

ARVO Annual Meeting Abstract June 2023

Ocular surface platelet-rich plasma membranes: setting preparation conditions

Alberto Castilo; Judith Zavala; Katiana Flores Nucamendi; David Rodriguez; Alfredo Del Castillo; Jorge E Valdez

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5167.

ARVO Annual Meeting Abstract June 2023

Antifibrotic activity of Siempreviva sap for potential pterygium treatment

Katiana Flores Nucamendi; Mairobi Persinal-Medina; David Eguenio Rodriguez; Alfredo Del Castillo; Karla Carrasco; Daniel Dares; Alberto Castilo; Judith Zavala; Jorge E Valdez

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):206.

ARVO Annual Meeting Abstract June 2023

Underrepresentation of low-and middle-income nations in Ophthalmology journals: A critical analysis on diversity, equity, and global representation

Eugenia Margarita Ramos Dávila; Luis Guillermo Villagomez Valdez; Irving Armando Dominguez Varela; Diego Lopez Zuñiga; Raul Eduardo Ruiz Lozano; Nestor Ibarra Salazar; Jorge E. Valdez

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5369.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Key Clinical and Histopathological Features of a Pterygium-Like Induced Lesion in a Rabbit Model

Key clinical features of the progression of a Pterygium-Like Induced Lesion in a rabbit model

Effect of low-dose Sedum sp. lyophilate in sodium hyaluronate solution on the resazurin viability assay of human pterygium fibroblasts

Safety profile of Siempreviva formulation in an in vivo model

Efficacy and Safety of Off-Label Subconjunctival Ranibizumab for Pterygium Recurrence

Therapeutic effect of a Siempreviva formulation in a pterygium in vivo model

Establishing Optimal Parameters for Tissue Engineered Corneal Endothelium

Clinical Features and Treatment Outcomes in Patients Diagnosed with Late LASIK Ectasia

Visual acuity and refraction in patients with LASIK enhancement

From Retina to Cornea: Quantifying the Impact of Diabetic Retinopathy on Dry Eye Disease and Corneal Sensitivity

Clinical Profile of Ophthalmology Patients Using Biologic Therapy and Predictive Factors for Switching

Enhanced Wound Healing in a Conjunctival Epithelial Cell Scratch Assay via Platelet and Leukocyte Rich Plasma Enriched in Platelet-Derived Growth Factor

Degradation Rate and Water Absorption Characterization of Collagen Membranes for Corneal Tissue Engineering

Meibomian gland dysfunction treated with a novel device: A case series

Underrepresentation of Low- and Middle-Income Nations in Ophthalmology Journals: A Critical Analysis on Diversity, Equity, and Global Representation

Corneal Biomechanical Metrics by Corvis ST in a Healthy Mexican Population

Quality-adjusted life year analysis of engineered corneal endothelium transplant for a Hispanic Population

Ocular surface platelet-rich plasma membranes: setting preparation conditions

Antifibrotic activity of Siempreviva sap for potential pterygium treatment

Underrepresentation of low-and middle-income nations in Ophthalmology journals: A critical analysis on diversity, equity, and global representation

To View More...

You must be signed into an individual account to use this feature.